Table 1. Demographic and Prognostically... | American Society of Hematology

Table 1.

Demographic and Prognostically Relevant Clinical and Laboratory Parameters

	Group A	Group B	Group C
	Meningitis Without Shock	Meningitis With Shock	Shock Without Meningitis
No. female/male	14/12	7/6	6/14
Age, yr	14 (1-64)	5 (0-21)	3^‡ (0-30)
Duration of disease before admission, h	24.0 (12.5-84)	14.0ρ (3.0-30)	12.0^1-155 (2.8-16.5)
Leukocytes in CSF, × 10⁶/L	12,300 (>100-70,000)	434^1-155 (101-19,100)	15^∥¶ (1-98)
Peripheral leukocytes*, × 10⁹/L	19.5 (10.5-29.9)	11.4ρ (2.4-26.8)	3.8^1-155 (1.4-13.6)
Platelets*, × 10⁹/L	158 (51-388)	70^‡ (39-325)	47^1-155 (16-171)
Fibrinogen*, mg/L	5,200 (3,500-12,000)	2,400^1-155 (230-4,115)	1,183^1-155 (90-3,732)
Lactate†, μmol/L	2,123 (409-4,070)	3,412^‡ (1,806-7,013)	5,108^1-155 (1,529-14,087)
No. of fatalities	2 (8%)	1 (8%)	6 (30%)

	Group A	Group B	Group C
	Meningitis Without Shock	Meningitis With Shock	Shock Without Meningitis
No. female/male	14/12	7/6	6/14
Age, yr	14 (1-64)	5 (0-21)	3^‡ (0-30)
Duration of disease before admission, h	24.0 (12.5-84)	14.0ρ (3.0-30)	12.0^1-155 (2.8-16.5)
Leukocytes in CSF, × 10⁶/L	12,300 (>100-70,000)	434^1-155 (101-19,100)	15^∥¶ (1-98)
Peripheral leukocytes*, × 10⁹/L	19.5 (10.5-29.9)	11.4ρ (2.4-26.8)	3.8^1-155 (1.4-13.6)
Platelets*, × 10⁹/L	158 (51-388)	70^‡ (39-325)	47^1-155 (16-171)
Fibrinogen*, mg/L	5,200 (3,500-12,000)	2,400^1-155 (230-4,115)	1,183^1-155 (90-3,732)
Lactate†, μmol/L	2,123 (409-4,070)	3,412^‡ (1,806-7,013)	5,108^1-155 (1,529-14,087)
No. of fatalities	2 (8%)	1 (8%)	6 (30%)

Medians are shown, range between brackets.

Abbreviation: CSF, cerebrospinal fluid.

Nadir* or maximum measured within the first 12 hours after admission.

Maximum† measured within the first 12 hours after admission.

Compared to group A:

P < .05.

ρ P < .01.

P < .001.

Compared to group B:

P < .001.